keyword
Keywords Telangiectasia macularis erupt...

Telangiectasia macularis eruptiva perstans

https://read.qxmd.com/read/38248039/challenges-in-the-diagnosis-of-cutaneous-mastocytosis
#1
REVIEW
Knut Brockow, Rebekka Karolin Bent, Simon Schneider, Sophie Spies, Katja Kranen, Benedikt Hindelang, Zsuzsanna Kurgyis, Sigurd Broesby-Olsen, Tilo Biedermann, Clive E Grattan
BACKGROUND: Mastocytosis is characterized by an accumulation of clonal mast cells (MCs) in tissues such as the skin. Skin lesions in mastocytosis may be clinically subtle or heterogeneous, and giving the correct diagnosis can be difficult. METHODS: This study compiles personal experiences together with relevant literature, discussing possible obstacles encountered in diagnosing skin involvement in mastocytosis and cutaneous mastocytosis (CM). RESULTS: The nomenclature of the term "CM" is ambiguous...
January 11, 2024: Diagnostics
https://read.qxmd.com/read/37431121/telangiectasia-macularis-eruptiva-perstans-associated-with-multiple-myeloma
#2
JOURNAL ARTICLE
Huai-Yu Wang, Chang-Hua Zhu, Qian Zheng, Lin-Xin Dong, Li-Hang Lin, Xue-Min Xiao
No abstract text is available yet for this article.
April 1, 2023: European Journal of Dermatology: EJD
https://read.qxmd.com/read/37318879/unusual-presentation-of-telangiectasia-macularis-eruptiva-perstans-at-the-site-of-healed-herpes-zoster-wolf-s-isotopic-response
#3
JOURNAL ARTICLE
Sameh Sarsik, Sarah H Soliman, Rofyda Essam Elhalaby
There are several reported cases of Wolf's isotopic response, including infections, cancers, inflammatory and immune-related disorders. It is interesting that the majority of these occurred after herpes zoster (HZ) had healed. In this article, we describe an unusual case of adult mastocytosis/telangiectasia macularis eruptiva perstans (TMEP) at the location of recovered HZ. Given that adult mastocytosis is thought to be caused by dysregulation of the mast cell growth factor receptor, the c-Kit proto-oncogene (CD117), and the fact that the varicella zoster virus-infected cutaneous lesions contain CD117-positive mast cells (CD117+MCs), we hypothesize that CD117+ MCs may be in charge of the local immunological response and cytokine release those results in TMEP after HZ...
June 15, 2023: Australasian Journal of Dermatology
https://read.qxmd.com/read/36301773/dermpath-clinic-telangiectasia-macularis-eruptiva-perstans
#4
JOURNAL ARTICLE
Juan Luis Castaño-Fernandez, Francisco Jose Rodriguez-Cuadrado, Irene Sanchez-Gutierrez, Laura Najera-Botello, Irene Salguero Fernandez, Gaston Roustan Gullon, Angel Manuel Rosell-Diaz
No abstract text is available yet for this article.
July 1, 2022: European Journal of Dermatology: EJD
https://read.qxmd.com/read/36012900/dermoscopic-features-of-different-forms-of-cutaneous-mastocytosis-a-systematic-review
#5
REVIEW
Martyna Sławińska, Agnieszka Kaszuba, Magdalena Lange, Roman J Nowicki, Michał Sobjanek, Enzo Errichetti
The term mastocytosis refers to a heterogeneous group of disorders characterised by accumulation of clonal mast cells in different organs, most commonly in the skin. Little is known about the role of dermoscopy in the diagnostics of mastocytosis. To date, no systematic review on the dermoscopic features of cutaneous mastocytosis has been performed. The aim of this study was to summarise the current knowledge in the field as well as to identify the knowledge gaps to show possible directions for further studies, based on a systematic search of PubMed, Scopus, and Web of Science databases and related references published before 3 January 2022...
August 9, 2022: Journal of Clinical Medicine
https://read.qxmd.com/read/35859252/progress-of-telangiectasia-macularis-eruptiva-perstans-exacerbated-egg-allergy
#6
JOURNAL ARTICLE
Naohiro Itoh, Motoko Yasutomi, Noritaka Oyama, Minoru Hasegawa, Yusei Ohshima
No abstract text is available yet for this article.
January 2022: Pediatrics International: Official Journal of the Japan Pediatric Society
https://read.qxmd.com/read/35847419/persistent-facial-flushing-in-a-patient-with-telangiectasia-macularis-eruptiva-perstans-an-unusual-but-should-emphasized-clinical-finding
#7
Xigetu He, Bailing Wang, Xiujuan Jia, Yanfei Li, Hongxia Yan, Qiri Mu, Shana Chen
Facial flushing is one of the common conditions in dermatology, which affects the aesthetic of patients to a great extent, and even leads to psychological and economic burdens. The most common causes of facial flushing are often inflammatory skin diseases such as rosacea, contact dermatitis, and others, but the facial flushing as a sign can also be the cutaneous manifestation of systemic disease. Telangiectasia macularis eruptiva perstans (TMEP) is a rare disease associated with mast cells. Here, we describe an unusual clinical finding with persistent facial flushing in a patient with TMEP...
2022: Clinical, Cosmetic and Investigational Dermatology
https://read.qxmd.com/read/35774223/progressive-ascending-telangiectasias
#8
JOURNAL ARTICLE
Avanika Mahajan, Loren Zech, John R Durkin
No abstract text is available yet for this article.
June 2022: JAAD Case Reports
https://read.qxmd.com/read/35647249/successful-treatment-of-psoriasis-with-risankizumab-in-a-patient-with-telangiectasia-macularis-eruptiva-perstans
#9
Cara Barber, Eingun James Song
No abstract text is available yet for this article.
June 2022: JAAD Case Reports
https://read.qxmd.com/read/35082619/newly-developed-psoriasis-in-a-patient-with-telangiectasia-macularis-eruptiva-perstans-and-systemic-mastocytosis-treated-with-interferon
#10
Tatiana Péčová, Tatiana Burjanivová, Bibiana Malicherová, Martin Jozef Péč, Igor Rohoň, Matúš Madleňák, Katarína Adamicová, Juraj Péč
The authors present a rare case of a patient with telangiectasia macular eruptiva perstans, with confirmed D816V mutation which later progressed to systemic mastocytosis confirmed by trepanobiopsy. First-line treatment - phototherapy - had to be stopped, and systemic treatment with interferon alpha-2a was initiated. The treatment was successful with regression of skin lesions as well as mast cell infiltrates in the bone marrow. However, the treatment was complicated by the onset of psoriasis lesions.
September 2021: Case Reports in Dermatology
https://read.qxmd.com/read/34797809/telangiectasia-macularis-eruptiva-perstans-of-the-scalp-mimicking-angiosarcoma
#11
JOURNAL ARTICLE
Marc Lawrence, James Sampson, Fergus Oliver, Paul Restall, Monique Mackenzie
We present a case of a 74-year-old man with marked photodamage who was ultimately diagnosed with telangiectasia macularis eruptiva perstans (TMEP) of the scalp. The diagnosis was made more difficult because of the clinical and histological similarity of this case with an early angiosarcoma. TMEP is a benign and indolent rare subtype of cutaneous mastocytosis presenting clinically with red-brown telangiectatic macules, usually symmetrically distributed over the trunk and extremities. Although most cases are limited to the skin, systemic involvement can occur, and this can be a potentially life-threatening disease...
December 1, 2021: American Journal of Dermatopathology
https://read.qxmd.com/read/34477069/maculopapular-cutaneous-mastocytosis-successfully-treated-with-omalizumab
#12
JOURNAL ARTICLE
Leftheria Tampouratzi, Theodora Kanni, John Katsantonis, Theodora Douvali
Dear Editor, Maculopapular cutaneous mastocytosis (MPCM), formerly telangiectasia macularis eruptiva perstans (TMEP), is an uncommon form of cutaneous mastocytosis first described on 1930 (1). It is more frequent in adults, and early diagnosis is crucial since it has been reported to be associated with serious underlying systemic disorders, such as myeloproliferative diseases and severe manifestations like anaphylaxis (2,3). Treatment of MPCM depends on the presence of systemic involvement and/or the clinical symptoms of the disease itself...
April 2021: Acta Dermatovenerologica Croatica: ADC
https://read.qxmd.com/read/34314029/a-case-of-omalizumab-as-a-successful-treatment-for-telangiectasia-macularis-eruptiva-perstans
#13
JOURNAL ARTICLE
Alexandra Maria Mortimore, Ramez Barsoum, Duncan Lambie, Erin McMeniman
Treatment for telangiectasia macularis eruptiva perstans (TMEP) is often challenging due to lack of an established first-line therapy and as such is primarily focused on symptomatic relief. Omalizumab shows promise as a potential therapy for mast cell disorders; however, its efficacy in TMEP is yet to be established. This case describes a 72-year-old woman with chronic refractory TMEP achieving symptomatic remission within 4 months of commencing omalizumab therapy.
February 2022: Australasian Journal of Dermatology
https://read.qxmd.com/read/32382640/telangiectasia-macularis-eruptiva-perstans-in-the-presence-of-liver-cirrhosis
#14
Alisen Huang, Ankuri Desai, Nooshin Brinster, Shoshana Marmon
No abstract text is available yet for this article.
May 2020: JAAD Case Reports
https://read.qxmd.com/read/32238242/-cutaneous-manifestations-in-mastocytosis-update
#15
REVIEW
Sandra Ferreira, Iolanda Fernandes, Renata Cabral, Susana Machado, Margarida Lima, Manuela Selores
INTRODUCTION: Mastocytosis is characterized by the clonal expansion of morphological and immunophenotypically abnormal mast cells in different organs. The skin is the most frequently affected tissue. Virtually all children and more than 80% of adult patients with mastocytosis show cutaneous lesions. MATERIAL AND METHODS: The present article describes the symptoms and signs in cutaneous mastocytosis, based on the review of recently published international consensus guidelines...
April 1, 2020: Acta Médica Portuguesa
https://read.qxmd.com/read/32055534/dermoscopy-of-telangiectasia-macularis-eruptiva-perstans
#16
JOURNAL ARTICLE
Smriti Kumar, Deepak Jakhar, Rachita Misri
No abstract text is available yet for this article.
January 2020: Indian Dermatology Online Journal
https://read.qxmd.com/read/31394139/jaad-game-changers-telangiectasia-macularis-eruptiva-perstans-tmep-a-form-of-cutaneous-mastocytosis-with-potential-systemic-involvement
#17
COMMENT
Adam J Friedman
No abstract text is available yet for this article.
February 2020: Journal of the American Academy of Dermatology
https://read.qxmd.com/read/30973331/telangiectasia-macularis-eruptiva-perstans-a-neglected-type-of-mastocytosis-with-exclusively-cutaneous-involvement-a-case-series
#18
JOURNAL ARTICLE
Andrea Michelerio, Sara Grassi, Chiara Elena, Giorgio Alberto Croci, Emanuela Boveri, Grazia Bossi, Valeria Brazzelli
Telangiectasia macularis eruptiva perstans (TMEP) is a rare form of cutaneous mastocytosis (CM). Although TMEP has been traditionally thought to be restricted to the skin, a recent retrospective multicentric study established a diagnosis with systemic involvement of mastocytosis in 47% patients affected by TMEP and aggressive systemic mastocytosis in 9%. To evaluate systemic involvement in patients affected by TMEP. We conducted a retrospective monocentric study among patients affected by TMEP visited in our dermatology clinic...
April 1, 2019: European Journal of Dermatology: EJD
https://read.qxmd.com/read/30785120/pseudoxanthomatous-or-xanthelasmoid-mastocytosis-reporting-a-rare-entity
#19
JOURNAL ARTICLE
Preema Sinha, Sunmeet Sandhu, Arijit Sen, Aradhana Sood
Mastocytosis is a disease characterized by abnormal and pathologic increase in mast cells in the cutaneous tissue and extracutaneous organs such as the bone marrow, liver, spleen, lymph node and gastrointestinal tract. Cutaneous mastocytosis comprises of four major clinical variants: solitary and multiple mastocytomas, urticaria pigmentosa, diffuse cutaneous mastocytosis and telangiectasia macularis eruptiva perstans. Cutaneous mastocytosis of the xanthelasmoid type is a rare variant of diffuse mastocytosis...
July 2020: Indian Journal of Dermatology, Venereology and Leprology
https://read.qxmd.com/read/30142740/cutaneous-collagenous-vasculopathy-development-after-coronary-artery-bypass-surgery
#20
JOURNAL ARTICLE
Sahand Rahnama-Moghadam, Callie Burgin, Juliana Gilbert, Simon Warren
Cutaneous collagenous vasculopathy (CCV) is a rare benign microangiopathy of the superficial dermal vessels. Clinically, it is characterized by widespread, asymptomatic development of cutaneous telangiectasia in the absence of systemic symptoms. Morphologically, it most resembles generalized essential telangiectasia and other telangiectatic syndromes such as telangiectasia macularis eruptiva perstans (TMEP), ataxia telangiectasia, and hereditary hemorrhagic telangiectasia. It is distinctive in its histology, showing characteristic dilated thick-walled blood vessels in the superficial dermis...
May 15, 2018: Dermatology Online Journal
keyword
keyword
187283
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.